{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T15:20:43Z","timestamp":1777476043916,"version":"3.51.4"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T00:00:00Z","timestamp":1777334400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T00:00:00Z","timestamp":1777334400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100017650","name":"Three Lakes Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017650","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Clin Sleep Med"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s44470-026-00054-2","type":"journal-article","created":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T13:54:47Z","timestamp":1777384487000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The impact of obstructive sleep apnea on idiopathic pulmonary fibrosis clinical outcomes"],"prefix":"10.1007","volume":"22","author":[{"given":"Amina","family":"Hamza","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David A.","family":"Helfinstine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle B.","family":"Herberts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1664-7058","authenticated-orcid":false,"given":"Eric J.","family":"Olson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy M.","family":"Dempsey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew H.","family":"Limper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,28]]},"reference":[{"issue":"5","key":"54_CR1","doi-asserted-by":"publisher","first-page":"e44","DOI":"10.1164\/rccm.201807-1255ST","volume":"198","author":"G Raghu","year":"2018","unstructured":"Raghu G, Remy-Jardin M, Myers JL, et al. Diagnosis of idiopathic pulmonary fibrosis: an official ATS\/ERS\/JRS\/ALAT clinical practice guideline. Am J Respir Crit Care Med. 2018;198(5):e44\u201368. https:\/\/doi.org\/10.1164\/rccm.201807-1255ST.","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"54_CR2","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.medcli.2022.02.020","volume":"159","author":"F Le\u00f3n-Rom\u00e1n","year":"2022","unstructured":"Le\u00f3n-Rom\u00e1n F, Valenzuela C, Molina-Molina M. Idiopathic pulmonary fibrosis. Fibrosis pulmonar idiop\u00e1tica. Med Clin (Barc). 2022;159(4):189\u201394. https:\/\/doi.org\/10.1016\/j.medcli.2022.02.020.","journal-title":"Med Clin (Barc)"},{"issue":"17","key":"54_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11175008","volume":"11","author":"FF Karuga","year":"2022","unstructured":"Karuga FF, Kaczmarski P, Szmyd B, Bia\u0142asiewicz P, Sochal M, Gabryelska A. The association between idiopathic pulmonary fibrosis and obstructive sleep apnea: a systematic review and meta-analysis. J Clin Med. 2022;11(17):5008. https:\/\/doi.org\/10.3390\/jcm11175008.","journal-title":"J Clin Med"},{"issue":"9","key":"54_CR4","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1093\/aje\/kws342","volume":"177","author":"PE Peppard","year":"2013","unstructured":"Peppard PE, Young T, Barnet JH, Palta M, Hagen EW, Hla KM. Increased prevalence of sleep-disordered breathing in adults. Am J Epidemiol. 2013;177(9):1006\u201314. https:\/\/doi.org\/10.1093\/aje\/kws342.","journal-title":"Am J Epidemiol"},{"key":"54_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.smrv.2021.101442","volume":"58","author":"YH Khor","year":"2021","unstructured":"Khor YH, Ryerson CJ, Landry SA, et al. Interstitial lung disease and obstructive sleep apnea. Sleep Med Rev. 2021;58:101442. https:\/\/doi.org\/10.1016\/j.smrv.2021.101442.","journal-title":"Sleep Med Rev"},{"issue":"3","key":"54_CR6","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.ccm.2014.06.006","volume":"35","author":"CH Won","year":"2014","unstructured":"Won CH, Kryger M. Sleep in patients with restrictive lung disease. Clin Chest Med. 2014;35(3):505\u201312. https:\/\/doi.org\/10.1016\/j.ccm.2014.06.006.","journal-title":"Clin Chest Med"},{"key":"54_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2021.108165","volume":"100","author":"M Xiong","year":"2021","unstructured":"Xiong M, Zhao Y, Mo H, Yang H, Yue F, Hu K. Intermittent hypoxia increases ROS\/HIF-1\u03b1\u2013related oxidative stress and inflammation and worsens bleomycin-induced pulmonary fibrosis in adult male C57BL\/6J mice. Int Immunopharmacol. 2021;100:108165. https:\/\/doi.org\/10.1016\/j.intimp.2021.108165.","journal-title":"Int Immunopharmacol"},{"issue":"12","key":"54_CR8","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.1513\/AnnalsATS.201701-091OC","volume":"14","author":"JS Kim","year":"2017","unstructured":"Kim JS, Podolanczuk AJ, Borker P, et al. Obstructive Sleep Apnea and Subclinical Interstitial Lung Disease in the Multi-Ethnic Study of Atherosclerosis (MESA). Ann Am Thorac Soc. 2017;14(12):1786\u201395. https:\/\/doi.org\/10.1513\/AnnalsATS.201701-091OC.","journal-title":"Ann Am Thorac Soc"},{"key":"54_CR9","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/510105","volume":"2015","author":"A Adegunsoye","year":"2015","unstructured":"Adegunsoye A, Balachandran J. Inflammatory response mechanisms exacerbating hypoxemia in coexistent pulmonary fibrosis and sleep apnea. Mediators Inflamm. 2015;2015: 510105. https:\/\/doi.org\/10.1155\/2015\/510105.","journal-title":"Mediators Inflamm"},{"issue":"7","key":"54_CR10","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1377\/hlthaff.2014.0038","volume":"33","author":"PJ Wallace","year":"2014","unstructured":"Wallace PJ, Shah ND, Dennen T, Bleicher PA, Crown WH. Optum labs: building a novel node in the learning health care system. Health Aff (Millwood). 2014;33(7):1187\u201394. https:\/\/doi.org\/10.1377\/hlthaff.2014.0038.","journal-title":"Health Aff (Millwood)"},{"issue":"1","key":"54_CR11","doi-asserted-by":"publisher","DOI":"10.1186\/s12890-023-02565-7","volume":"23","author":"MB Herberts","year":"2023","unstructured":"Herberts MB, Teague TT, Thao V, et al. Idiopathic pulmonary fibrosis in the United States: time to diagnosis and treatment. BMC Pulm Med. 2023;23(1):281. https:\/\/doi.org\/10.1186\/s12890-023-02565-7.","journal-title":"BMC Pulm Med"},{"issue":"4","key":"54_CR12","doi-asserted-by":"publisher","first-page":"2301299","DOI":"10.1183\/13993003.01299-2023","volume":"62","author":"TM Dempsey Jr","year":"2023","unstructured":"Dempsey TM, Thao V, Helfinstine DA Jr, Chang YH, Sangaralingham L, Limper AH Real-world cohort evaluation of the impact of the antifibrotics in patients with idiopathic pulmonary fibrosis. Eur Respir J. 2023;62(4):2301299. https:\/\/doi.org\/10.1183\/13993003.01299-2023.","journal-title":"Eur Respir J"},{"issue":"7","key":"54_CR13","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1513\/AnnalsATS.202007-901OC","volume":"18","author":"TM Dempsey","year":"2021","unstructured":"Dempsey TM, Payne S, Sangaralingham L, Yao X, Shah ND, Limper AH. Adoption of the antifibrotic medications pirfenidone and nintedanib for patients with idiopathic pulmonary fibrosis. Ann Am Thorac Soc. 2021;18(7):1121\u20138. https:\/\/doi.org\/10.1513\/AnnalsATS.202007-901OC.","journal-title":"Ann Am Thorac Soc"},{"issue":"3","key":"54_CR14","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1002\/pst.537","volume":"11","author":"E Gayat","year":"2012","unstructured":"Gayat E, Resche-Rigon M, Mary JY, Porcher R. Propensity score applied to survival data analysis through proportional hazards models: a Monte Carlo study. Pharm Stat. 2012;11(3):222\u20139. https:\/\/doi.org\/10.1002\/pst.537.","journal-title":"Pharm Stat"},{"issue":"1","key":"54_CR15","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/s11325-014-1033-6","volume":"19","author":"C Mermigkis","year":"2015","unstructured":"Mermigkis C, Bouloukaki I, Antoniou K, et al. Obstructive sleep apnea should be treated in patients with idiopathic pulmonary fibrosis. Sleep Breath. 2015;19(1):385\u201391. https:\/\/doi.org\/10.1007\/s11325-014-1033-6.","journal-title":"Sleep Breath"},{"issue":"4","key":"54_CR16","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1007\/s11325-013-0813-8","volume":"17","author":"C Mermigkis","year":"2013","unstructured":"Mermigkis C, Bouloukaki I, Antoniou KM, et al. CPAP therapy in patients with idiopathic pulmonary fibrosis and obstructive sleep apnea: does it offer a better quality of life and sleep? Sleep Breath. 2013;17(4):1137\u201343. https:\/\/doi.org\/10.1007\/s11325-013-0813-8.","journal-title":"Sleep Breath"},{"issue":"5","key":"54_CR17","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1007\/s00408-017-0031-4","volume":"195","author":"M Bosi","year":"2017","unstructured":"Bosi M, Milioli G, Fanfulla F, et al. OSA and prolonged oxygen desaturation during sleep are strong predictors of poor outcome in IPF. Lung. 2017;195(5):643\u201351. https:\/\/doi.org\/10.1007\/s00408-017-0031-4.","journal-title":"Lung"},{"issue":"5","key":"54_CR18","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1016\/j.chest.2021.06.049","volume":"160","author":"T Petnak","year":"2021","unstructured":"Petnak T, Lertjitbanjong P, Thongprayoon C, Moua T. Impact of antifibrotic therapy on mortality and acute exacerbation in idiopathic pulmonary fibrosis: a systematic review and meta-analysis. Chest. 2021;160(5):1751\u201363. https:\/\/doi.org\/10.1016\/j.chest.2021.06.049.","journal-title":"Chest"},{"issue":"2","key":"54_CR19","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1164\/rccm.201902-0456OC","volume":"200","author":"TM Dempsey","year":"2019","unstructured":"Dempsey TM, Sangaralingham LR, Yao X, Sanghavi D, Shah ND, Limper AH. Clinical effectiveness of antifibrotic medications for idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2019;200(2):168\u201374. https:\/\/doi.org\/10.1164\/rccm.201902-0456OC.","journal-title":"Am J Respir Crit Care Med"},{"key":"54_CR20","unstructured":"Barnett JC, Vornovitsky MS. Health insurance coverage in the United States: 2015. Washington, DC:United States Census Bureau; 2016. P60\u2013257(RV). https:\/\/www.census.gov\/content\/dam\/Census\/library\/publications\/2016\/demo\/p60-257.pdf."},{"issue":"1","key":"54_CR21","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1183\/13993003.01653-2015","volume":"48","author":"G Raghu","year":"2016","unstructured":"Raghu G, Chen SY, Hou Q, Yeh WS, Collard HR. Incidence and prevalence of idiopathic pulmonary fibrosis in US adults 18-64 years old. Eur Respir J. 2016;48(1):179\u201386. https:\/\/doi.org\/10.1183\/13993003.01653-2015.","journal-title":"Eur Respir J"},{"issue":"7","key":"54_CR22","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1164\/rccm.200602-163OC","volume":"174","author":"G Raghu","year":"2006","unstructured":"Raghu G, Weycker D, Edelsberg J, Bradford WZ, Oster G. Incidence and prevalence of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2006;174(7):810\u20136. https:\/\/doi.org\/10.1164\/rccm.200602-163OC.","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"54_CR23","doi-asserted-by":"publisher","first-page":"829","DOI":"10.3111\/13696998.2012.680553","volume":"15","author":"HR Collard","year":"2012","unstructured":"Collard HR, Ward AJ, Lanes S, Hayflinger DC, Rosenberg DM, Hunsche E. Burden of illness in idiopathic pulmonary fibrosis. J Med Econ. 2012;15(5):829\u201335. https:\/\/doi.org\/10.3111\/13696998.2012.680553.","journal-title":"J Med Econ"},{"issue":"7","key":"54_CR24","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1513\/AnnalsATS.201412-553OC","volume":"12","author":"HR Collard","year":"2015","unstructured":"Collard HR, Chen SY, Yeh WS, et al. Health care utilization and costs of idiopathic pulmonary fibrosis in U.S. Medicare beneficiaries aged 65 years and older. Ann Am Thorac Soc. 2015;12(7):981\u20137. https:\/\/doi.org\/10.1513\/AnnalsATS.201412-553OC.","journal-title":"Ann Am Thorac Soc"}],"container-title":["Journal of Clinical Sleep Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s44470-026-00054-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s44470-026-00054-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s44470-026-00054-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T13:54:49Z","timestamp":1777384489000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s44470-026-00054-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,28]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["54"],"URL":"https:\/\/doi.org\/10.1007\/s44470-026-00054-2","relation":{},"ISSN":["1550-9389","1550-9397"],"issn-type":[{"value":"1550-9389","type":"print"},{"value":"1550-9397","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,28]]},"assertion":[{"value":"24 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The requirement for informed consent was waived by the Mayo Clinic Institutional Review Board due to the retrospective nature of the study and use of de-identified data.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"All authors identified above have seen and approve this manuscript for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The sponsor had no role in the design of the study, the data collection and analysis, nor the preparation of the manuscript.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Role of sponsors"}}],"article-number":"68"}}